BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6607509)

  • 1. Monoclonal B cells in peripheral blood in non-Hodgkin's lymphoma. Correlation with clinical features and DNA content.
    Lindh J; Lenner P; Roos G
    Scand J Haematol; 1984 Jan; 32(1):5-11. PubMed ID: 6607509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating monoclonal B lymphocytes in non-Hodgkin's lymphoma.
    Smith BR; Weinberg DS; Robert NJ; Towle M; Luther E; Pinkus GS; Ault KA
    N Engl J Med; 1984 Dec; 311(23):1476-81. PubMed ID: 6438505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytofluorometric detection of B cell clonal excess: a new approach to the diagnosis of B cell lymphoma.
    Weinberg DS; Pinkus GS; Ault KA
    Blood; 1984 May; 63(5):1080-7. PubMed ID: 6424737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic analysis by flow cytometry of surface immunoglobulin light chains and B and T cell antigens in lymph nodes involved with non-Hodgkin's lymphoma.
    Liendo C; Danieu L; Al-Katib A; Koziner B
    Am J Med; 1985 Oct; 79(4):445-54. PubMed ID: 3931469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
    Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
    J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T and B lymphocytes in non-Hodgkin's lymphoma: a comparison of tumor-derived cells and peripheral blood lymphocytes.
    Noguchi S; Bukowski R; Deodhar S; Hewlett JS
    Cancer; 1976 May; 37(5):2247-54. PubMed ID: 1083288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of lymphocyte surface markers in adult non-Hodgkin's malignant lymphoma.
    Bloomfield CD; Kersey JH; Brunning RD; Gajl-Peczalska KJ
    Lancet; 1976 Dec; 2(7999):1330-3. PubMed ID: 63805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The biology of tumor growth in the non-Hodgkin's lymphomas. A dual parameter flow cytometry study of 220 cases.
    Shackney SE; Levine AM; Fisher RI; Nichols P; Jaffe E; Schuette WH; Simon R; Smith CA; Occhipinti SJ; Parker JW
    J Clin Invest; 1984 Apr; 73(4):1201-14. PubMed ID: 6608531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface markers in non-Hodgkin's lymphomas.
    Rudders RA
    Hosp Pract (Off Ed); 1983 Jan; 18(1):161-4, 169-70, 172 passim. PubMed ID: 6401266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Flow cytometric analysis of surface phenotypes in B-cell non-Hodgkin's lymphoma].
    Chubachi A
    Rinsho Ketsueki; 1989 Dec; 30(12):2134-40. PubMed ID: 2516139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and prognostic significance of the T-B immunological classification of non-Hodgkin's lymphomas.
    Ogasawara H; Fujitani T; Mizojiri G; Hattori H
    Laryngoscope; 1981 Jan; 91(1):125-32. PubMed ID: 7005580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric light chain analysis of peripheral blood lymphocytes in patients with non-Hodgkin's lymphoma.
    Johnson A; Cavallin-Ståhl E; Akerman M
    Br J Cancer; 1985 Aug; 52(2):159-65. PubMed ID: 3927967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lymphocyte surface markers during treatment of non-Hodgkin's lymphomas].
    Trepińska E; Burchardt K
    Z Gesamte Inn Med; 1981 Sep; 36(18):681-2. PubMed ID: 6976047
    [No Abstract]   [Full Text] [Related]  

  • 14. Surface phenotyping, histology and the nature of non-Hodgkin lymphoma in 157 patients.
    Habeshaw JA; Catley PF; Stansfeld AG; Brearley RL
    Br J Cancer; 1979 Jul; 40(1):11-34. PubMed ID: 314300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometry analysis of murine B cell lymphoma differentiation.
    Warner NL; Daley MJ; Richey J; Spellman C
    Immunol Rev; 1979; 48():197-243. PubMed ID: 161906
    [No Abstract]   [Full Text] [Related]  

  • 16. The incidence of B cell leukaemia and lymphopenia in B cell neoplasia in adults: a study using the Kiel classification of non-Hodgkin's lymphoma.
    Cader A; Richardson P; Walsh L; Ling NR; MacLennan IC; Jones EL; Leyland M
    Br J Cancer; 1983 Aug; 48(2):185-93. PubMed ID: 6603860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies reactive in routinely processed tissue sections of malignant lymphoma, with emphasis on T-cell lymphomas.
    Strickler JG; Weiss LM; Copenhaver CM; Bindl J; McDaid R; Buck D; Warnke R
    Hum Pathol; 1987 Aug; 18(8):808-14. PubMed ID: 3301626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological characterization of non-Hodgkin's lymphoma: enrichment of neoplastic cells from lymphoid tissues and blood.
    Bom-Van Noorloos AA; Van Beek AA; Ubels-Postma J; Zeijlemaker WP; Van Heerde P; Von Dem Borne AE; Cleton FJ; Melief CJ
    Cancer; 1982 Apr; 49(8):1605-12. PubMed ID: 6978173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cellular content of non Hodgkin lymphomas: a comprehensive analysis using monoclonal antibodies and other surface marker techniques.
    Habeshaw JA; Bailey D; Stansfeld AG; Greaves MF
    Br J Cancer; 1983 Mar; 47(3):327-51. PubMed ID: 6338896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two monoclonal antibodies defining unique antigenic determinants on human B-lymphoma cells.
    Howard DR; Eaves AC; Takei F
    Cancer Res; 1985 Dec; 45(12 Pt 1):6322-7. PubMed ID: 2415242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.